Sequenom Acquired By LabCorp For $371M

San Diego-based prenatal testing provider Sequenom is being acquired by Laboratory Corporation of America (LabCorp), in a deal worth $371M, the companies said this morning. According to LabCorp, it has agreeed to pay $2.40 per share in cash for all of the outstanding shares of publicly held Sequenom, which trades as SQNM. Sequenom provides non-invasive prenatal testing (NIPT) for reproductive health. Sequenom is being advised by JP Morgan and Cooley LLP in the deal; LabCorp is being advised by Barclays and Hogan Lovells.